Counting of co-exposure
In this qualitative approach, the number of combinations of substances to which an individual is exposed are recorded, see Table 109. There is no cut-off level, the only criterion is the presence of a substance in the simulated daily diet or not. For an acute or short term exposure assessment, a simulated individual day is the smallest entity to determine co-exposure. For a chronic or long term exposure assessment, co-exposures are summarized at the individual level, e.g. co-exposure is determined combining all consumption days of an individual.
| Substance | day 1 | day 2 | day 3 | … | day n | 
|---|---|---|---|---|---|
| Tebuconazole | x | x | … | ||
| Bitertanol | x | x | … | x | |
| Triadimefon | x | … | … | x | |
| … | … | … | … | … | … | 
In Table 110, the frequency and percentage for the number of substances occurring together are shown.
| Number of substances | Frequency | Percentage | 
|---|---|---|
| 0 | 337 | 3.4 | 
| 1 | 959 | 9.6 | 
| 2 | 1207 | 12.1 | 
| 3 | 1275 | 12.8 | 
| … | … | … | 
In Table 111, the mixtures containing the substance(s) including all other combinations with the specified combination of substance(s), (a maximum number of 15 records is shown).
| Number of substances | Percentage | Substances | 
|---|---|---|
| 1 | 5.88 | Tebuconazole | 
| 2 | 3.88 | Imazalil (aka enilconazole), Tebuconazole | 
| 0 | 3.37 | |
| 3 | 2.20 | Difenoconazole, Imazalil (aka enilconazole), Tebuconazole | 
| 1 | 1.78 | Imazalil (aka enilconazole) | 
| 3 | 1.76 | Imazalil (aka enilconazole), Tebuconazole, Triadimenol | 
| … | … | … |